Tags

Type your tag names separated by a space and hit enter

Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa.
Adv Neurol. 1987; 45:535-8.AN

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Clinical Trial
Comparative Study
Controlled Clinical Trial
Journal Article

Language

eng

PubMed ID

3548263

Citation

Gawel, M, et al. "Bromocriptine in the Treatment of Parkinson's Disease: a Double-blind Study Against L-dopa/carbidopa." Advances in Neurology, vol. 45, 1987, pp. 535-8.
Gawel M, Riopelle R, Libman I, et al. Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Adv Neurol. 1987;45:535-8.
Gawel, M., Riopelle, R., Libman, I., & Bouchard, S. (1987). Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. Advances in Neurology, 45, 535-8.
Gawel M, et al. Bromocriptine in the Treatment of Parkinson's Disease: a Double-blind Study Against L-dopa/carbidopa. Adv Neurol. 1987;45:535-8. PubMed PMID: 3548263.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Bromocriptine in the treatment of Parkinson's disease: a double-blind study against L-dopa/carbidopa. AU - Gawel,M, AU - Riopelle,R, AU - Libman,I, AU - Bouchard,S, PY - 1987/1/1/pubmed PY - 1987/1/1/medline PY - 1987/1/1/entrez SP - 535 EP - 8 JF - Advances in neurology JO - Adv Neurol VL - 45 SN - 0091-3952 UR - https://www.unboundmedicine.com/medline/citation/3548263/Bromocriptine_in_the_treatment_of_Parkinson's_disease:_a_double_blind_study_against_L_dopa/carbidopa_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -